Financials

  • Market Capitalization 4.41 B
  • Employee 137
  • Founded 2017
  • CEO N/A
  • Website www.tangotx.com
  • Headquarter Delaware, United States
  • FIGI BBG00WFDDRS0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-25.2
Relación precio/flujo de caja
43.08

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1426
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
25.95 USD+1.80%+0.62%+21.66%+17.53%4.44 B USD
1429
VKTX
Viking Therapeutics, Inc. - Common Stock
38.07 USD+0.26%-3.72%+29.05%+21.82%4.42 B USD
1439
EWTX
Edgewise Therapeutics, Inc. - Common Stock
40.72 USD+2.49%-11.73%+14.03%+167.37%4.38 B USD
1455
LEGN
Legend Biotech Corporation - American Depositary Shares
23.27 USD-9.35%-15.13%-33.53%-27.24%4.30 B USD

Noticias